7/27/2022CDE Publicizes the List of Reference Formulations for GQCE Studies (61...

7/26/2022Rona Therapeutics Licenses Sanofi's Broad siRNA Therapeutic Portfolio ...

7/26/2022NHSA and MOF Issues Notice to Further Implement BMI Inter-provincial M...

7/26/2022CDE Solicits Comments on the Draft Guidelines for Blinding Drug Clinic...

7/26/2022China Clears Domestically-made HIV Pill for COVID-19

7/26/2022MSD and Kelun Enter Oncology Research Collaboration and License Agre...

7/26/2022Nicholas Hall Reports Softening Chinese CHC and Analgesics Market Grow...

7/26/2022Snapshot: Top Ten Chinese New Drug Projects by Accumulative R&D Invest...

7/26/2022Review of Chinese Hospital Drug Market in Q1/2022

7/26/2022Mybio Capital's China Pharma BD Transactions Report H1/2022

7/26/2022Biotech fundraising in China Warms Up A Little in June (PharmaDJ)

7/26/2022Mobile Health Applications for Depression in China: A Systematic Revie...

7/22/2022Lilly and Triastek Tie Up to Explore the Application of 3D Printing Te...

7/22/2022AbbVie Terminates Early-stage Study of I-Mab's Antibody lemzoparlimab...

7/22/2022CDE Solicits Comments on the Draft Technical Guidelines for Drug Regis...

7/22/2022CDE Issues the List of Reference Formulations for GQCE Studies (56th B...

7/22/2022Two Chinese Biotechs Raise Millions for Shingles Vaccine Candidates to...

7/22/2022Novaremed Enters License Pact with NeuroFront for Non-opioid Neuropath...

7/22/2022Drug R&D and Product Registration News Digest July 2022 (3)

7/21/2022WuXi Biologics Plans to Build a Comprehensive CRDMO Center in Singapor...

7/21/2022A Practical Review of the New Supporting Regulations of China's Anti-M...

7/21/2022A Practical Review of the Amended Anti-Monopoly Law of China: Highligh...

7/21/2022Draft "Regulation on Prohibition for Abuse of IP Rights to Exclude or ...

7/20/2022China's Prospective Payment System: 3 Ways to Prepare

7/20/2022Official Data: Chinese Pharma Growth Slows in H1/2022

7/19/2022WuXi STA Opens a New Large Scale Continuous Manufacturing Plant

7/19/2022China To Establish National Demonstration Zones For IPR Protection

7/19/2022CNIPA: IP to Boost Bio-Economy Development in China

7/19/2022WuXi AppTec Plans to Build a New Site in Singapore with Planned S$2B I...

7/19/2022Brii Bio Announces Strategic Partnership with China Resources Pharma f...

Page:132/774 Total number of articles:23207: [First][<<] [130] [131] [132] [133] [134] [>>] [End]